These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 31358581)
1. A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection. Egui A; Thomas MC; Fernández-Villegas A; Pérez-Antón E; Gómez I; Carrilero B; Del Pozo Á; Ceballos M; Andrés-León E; López-Ruz MÁ; Gainza E; Oquiñena E; Segovia M; López MC Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358581 [TBL] [Abstract][Full Text] [Related]
2. Differential phenotypic and functional profile of epitope-specific cytotoxic CD8 Egui A; López MC; Gómez I; Simón M; Segovia M; Thomas MC Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165629. PubMed ID: 31816438 [TBL] [Abstract][Full Text] [Related]
3. Immunological exhaustion and functional profile of CD8 Pérez-Antón E; Egui A; Thomas MC; Simón M; Segovia M; López MC Acta Trop; 2020 Feb; 202():105242. PubMed ID: 31669531 [TBL] [Abstract][Full Text] [Related]
4. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients. Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791 [TBL] [Abstract][Full Text] [Related]
5. A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment. Pérez-Antón E; Egui A; Thomas MC; Carrilero B; Simón M; López-Ruz MÁ; Segovia M; López MC PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009059. PubMed ID: 33539379 [TBL] [Abstract][Full Text] [Related]
6. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies. Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678 [TBL] [Abstract][Full Text] [Related]
7. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial. Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S; J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946 [TBL] [Abstract][Full Text] [Related]
15. Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease. Vallejo A; Monge-Maillo B; Gutiérrez C; Norman FF; López-Vélez R; Pérez-Molina JA Acta Trop; 2016 Dec; 164():117-124. PubMed ID: 27619190 [TBL] [Abstract][Full Text] [Related]
16. Role of nucleic acid amplification assays in monitoring treatment response in chagas disease: Usefulness in clinical trials. Sulleiro E; Muñoz-Calderon A; Schijman AG Acta Trop; 2019 Nov; 199():105120. PubMed ID: 31376368 [TBL] [Abstract][Full Text] [Related]
17. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. Veloso VM; Carneiro CM; Toledo MJ; Lana M; Chiari E; Tafuri WL; Bahia MT Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):1005-11. PubMed ID: 11685270 [TBL] [Abstract][Full Text] [Related]
18. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280 [TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection. Fernández MC; González Cappa SM; Solana ME Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482 [TBL] [Abstract][Full Text] [Related]
20. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon. Teston AP; Monteiro WM; Reis D; Bossolani GD; Gomes ML; de Araújo SM; Bahia MT; Barbosa MG; Toledo MJ Trop Med Int Health; 2013 Jan; 18(1):85-95. PubMed ID: 23130989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]